Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06KKN
|
|||
Former ID |
DIB020267
|
|||
Drug Name |
LY2109761
|
|||
Synonyms |
LY-2109761; LY 2109761
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C26H27N5O2
|
|||
Canonical SMILES |
C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6
|
|||
InChI |
1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2
|
|||
InChIKey |
IHLVSLOZUHKNMQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 700874-71-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
16758637, 23756605, 49700621, 79852234, 103566348, 135723828, 136349564, 136367695, 137275861, 139858820, 144116157, 152159574, 152255061, 152258391, 152344392, 160647228, 162011469, 165246685, 172914060, 174006493, 174530316, 176237647, 180399204, 184816025, 208265510, 215783135, 223387286, 223438197, 223574706, 223705045, 225130378, 229727789, 242060149, 243147086, 245563668, 249565755, 249862162, 250207140, 252077501, 252215727, 252438714, 252553671
|
References | Top | |||
---|---|---|---|---|
REF 1 | LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol Cancer Ther. 2008 Apr;7(4):829-40. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.